CINCINNATI–(BUSINESS WIRE)–Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of
10 directors at the Company’s 2019 annual shareholders’ meeting. Each of
the directors continues from the prior term.
Shareholders ratified the continuation of PricewaterhouseCoopers LLP as
the Company’s independent accountants for 2019 and approved Chemed’s
executive compensation. In addition, shareholders voted in favor of
management’s recommendation to reject the shareholder proposal
requesting a semi-annual report on the Company’s policies on political
spending and political contributions made.
Dividend Declared
Following the shareholders’ meeting, Chemed’s Board of Directors
declared a quarterly cash dividend of 30 cents per share on the
Company’s capital stock, payable on June 19, 2019, to shareholders of
record as of May 30, 2019. This represents the 192nd consecutive
quarterly dividend paid to shareholders in Chemed’s 48 years as a public
company.
Listed on the New York Stock Exchange and headquartered in Cincinnati,
Ohio, Chemed Corporation (www.chemed.com)
operates two wholly owned subsidiaries: VITAS Healthcare and
Roto-Rooter. VITAS is the nation’s largest provider of end-of-life
hospice care, and Roto-Rooter is the nation’s leading provider of
plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications
may relate to future events or Chemed’s future performance. Such
statements are forward-looking statements and are based on present
information Chemed has related to its existing business circumstances.
Investors are cautioned that such forward-looking statements are
subject to inherent risk and that actual results may differ materially
from such forward-looking statements. Further, investors are
cautioned that Chemed does not assume any obligation to update
forward-looking statements based on unanticipated events or changed
expectations.
Contacts
David P. Williams
(513) 762-6901
